Equine encephalitis virus vaccine (Bavarian Nordic)
- Generic Name
- Equine encephalitis virus vaccine (Bavarian Nordic)
A Phase 2 Trial in Healthy Adult Participants of the Recombinant MVA-BN-WEV Vaccine
- First Posted Date
- 2025-03-28
- Last Posted Date
- 2025-03-28
- Lead Sponsor
- Bavarian Nordic
- Target Recruit Count
- 400
- Registration Number
- NCT06899802
- Locations
- 🇺🇸
Benchmark Research, San Angelo, Texas, United States
🇺🇸Lifeline Primary Care, Inc. / CCT Research, Lilburn, Georgia, United States
🇺🇸Clay-Platte Family Medicine, P.C./CCT Research, Kansas City, Missouri, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath